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Abstract
Background: Trauma resuscitation has undergone a paradigm shift with new emphasis on the early use of blood
products and increased proportions of plasma and platelets. However, it is unclear how this strategy is applied or
how effective it is in the elderly population. The study aim is to identify differences in transfusion practices and the
coagulopathy of trauma in the elderly.
Methods: Data was prospectively collected on all consecutive patients that met trauma activation criteria at a Level
I trauma centre. Data fields included patient demographics, co-morbidities, injury and resuscitation data, laboratory
values, thromboelastography (TEG) results, and outcome measures. Elderly patients were defined as those 55 and
older. Propensity-score matched analysis was completed for patients receiving blood product transfusion. Patients
were matched by gender, mechanism, injury severity score (ISS), head injury, and time from injury.
Results: Total of 628 patients were included, of which 142 (23%) were elderly. Elderly patients were more likely to
be female (41% vs. 24%), suffer blunt mechanism of trauma (96% vs. 80%), have higher ISS scores (mean 25.4 vs. 21.6)
and mortality (19% vs. 8%). Elderly patients were significantly more likely to receive a blood transfusion (42% vs. 30%),
specifically for red cells and plasma. Propensity-matched analysis resulted in no difference in red cell transfusion or
mortality. Despite the broad similarities between the matched cohorts, trauma coagulopathy as measured by TEG was
less commonly observed in the elderly.
Discussion: Our results suggest that elderly trauma patients are more likely to receive blood products when admitted
to a trauma centre, though this may be attributed to under-triage. The results also suggest an altered coagulopathic
response to traumatic injury which is partially influenced by increased anticoagulant and antiplatelet medication use in
the geriatric population.
Conclusion: It is not clear whether the acute coagulopathy of trauma is equivalent in geriatric patients, and further
study is therefore warranted.
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Background
Trauma resuscitation has undergone a paradigm shift over
the past decade. The benefit of early transfusion of blood
products has been realized and changed the approach to
the acutely injured, actively bleeding patient [1]. We have
also seen the adoption of increased ratios of fresh frozen
plasma (FFP) and platelets to packed red blood cells
(pRBC), and the development of specific transfusion
protocols to corral these efforts [2–4]. Despite limited
prospective data there has been wide-spread acceptance of
these changes in trauma resuscitation [5]. Furthermore,
there is even less data on how these new strategies in
transfusion have impacted specific subsets of the trauma
population, such as the elderly.
This shift in transfusion practices has largely been driven
by an improved understanding of the coagulopathy of
trauma, and the discovery that up to a quarter of severely
injured trauma patients will arrive to hospital already in a
coagulopathic state [6, 7]. This goes beyond the classic triad
of hypothermia, hemodilution, and acidosis and involves in-
trinsic mechanisms such as an accelerated and extensive ac-
tivation of tissue factor and activated protein C [6, 7]. This
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leads to a cascade resulting in hypocoagulability and hyper-
fibrinolysis, which are now recognized as independent pre-
dictors of ongoing hemorrhage and mortality [8, 9]. It
seems intuitive that this mechanism of trauma coagulopa-
thy would also occur in the elderly populations, though the
degree to which this occurs has been scarcely studied.
In order to diagnose acute trauma coagulopathy ex-
peditiously there has been increased utilization of point-
of-care coagulopathy testing, or viscoelastic hemostatic
assays, such as thromboelastography (TEG) and rota-
tional thromboelastometry (ROTEM). These tests are
able to provide rapid determination of coagulation status
and help guide transfusion practices [10–12]. However,
it is not known whether or not these tests maintain the
same accuracy in the elderly population. Scarpelini et al.
showed that TEG values in healthy volunteers did not
differ between the young and old, though this does not
necessarily extrapolate to the traumatized patient [13].
In fact, studies in peri-operative cardiac and orthopedic
surgery patients have shown differences in TEG-based
coagulation between the young and elderly, even after
controlling for pre-existing coagulopathies or anti-
coagulant medications [14, 15]. A separate coagulation
analysis of healthy volunteers revealed higher concentra-
tions of coagulation factors with age favoring increased
fibrin formation and reduced fibrinolysis [16]. Further
data also supports enhanced activation of the coagula-
tion system in frail elderly patients [17, 18], though again
the impact of these changes in the setting of trauma is
lacking and warrants further study.
It has been shown that geriatric patients are frequently
under-triaged to trauma centres [19–23]. In fact, in one
study elderly patients were half as likely to undergo trauma
team activation as younger patients with similar injury se-
verity [19]. This is in spite of evidence showing that the
majority of geriatric trauma patients have a chance at
achieving good functional outcomes and quality of life fol-
lowing major trauma [24, 25]. This brings to question
whether other facets of geriatric trauma care are similarly
under-delivered; a critical issue given the well-documented
correlation between trauma mortality and age [21].
Our hypotheses are two-fold. First, we hypothesized
that geriatric trauma patients are not treated equally
when it comes to transfusion of blood products. Specif-
ically, our study aimed to determine how age impacts
blood transfusion during trauma resuscitations. It has
been shown that geriatric trauma patients tend to be
under-triaged, but what is unclear is whether they are
under-resuscitated or over-resuscitated, given misleading
vital signs secondary to pre-existing medical conditions
and medication use [26]. Second, we hypothesized that
the acute coagulopathy of trauma varies with age. We
sought to specifically identify any differences in trauma
coagulopathy in-vivo in the elderly population.
Methods
A retrospective analysis was performed using prospect-
ively collected data on 790 consecutive patients that met
criteria for major trauma activation at a single Level I
trauma centre in Toronto, Canada from February to
October, 2007. Patients were excluded based on incom-
plete data, refusal of consent, or declaration of death on
arrival. This left 628 patients for further analysis. Data
collected included demographics, injury data, vital signs,
laboratory results (including TEG), and outcome data in-
cluding length of stay (LOS), complications, blood prod-
uct transfusion, and mortality. Primary complications of
interest were those associated with blood transfusion,
such as thromboembolic disease, infection rates, and
acute respiratory distress syndrome (ARDS). Of note,
the use of tranexamic acid in trauma patients was not
standard practice during the study period and was not
administered to any patients.
Elderly was defined as being 55 years of age and older.
Studies have shown that mortality tends to increase sig-
nificantly after 55, 65, and 70 years, and all of these time
points (and more) have been used to define elderly in
the literature [21, 27, 28]. Ideally, elderly would be de-
fined by the physiologic age at which systemic functions
start to decline and response to traumatic injury is im-
paired. Sadly, defining pre-injury physiologic age for each
individual patient is not feasible. Instead, we chose an age
cutoff of 55 in compliance with the current American Col-
lege of Surgeons’ Advanced Trauma Life Support (ATLS)
course recommendations for trauma triage [29]. This rec-
ommendation is based on population-based data showing
a major inflection in trauma mortality at this age [21].
Still, some of the recent literature has moved towards age
65 to define ‘elderly’. For this reason, we performed a
pre-planned subgroup analysis using an age cut-off of 65,
to confirm that our conclusions would remain relatively
consistent when using different definitions of elderly.
Basic descriptive comparisons between groups were
performed. We further analyzed the relationship be-
tween conventional laboratory tests and TEG values to
blood product transfusion. Patients that received at least
one unit of blood product transfusion were matched on
gender and a propensity score (within 0.2 standard devi-
ations) to one control subject. Patients that did not
undergo transfusion were excluded from the matched
analysis as the primary population of interest consisted of
patients suffering from traumatic hemorrhage and requir-
ing blood transfusion. The propensity score was calculated
using the following variables: mechanism of injury, time
to hospital, injury severity score (ISS), presence of head in-
jury (defined as head abbreviated injury score or AIS >0),
and operative management required. These covariates
were chosen because they are directly correlated with
blood transfusion [30], with the exception of head injury
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which was included as it has known effects on important
outcomes such as coagulopathy, LOS and mortality [31].
Subjects could serve as a control more than once.
Secondary analysis was performed to determine
whether abnormal TEG results could predict the need
for blood and blood product transfusion. A growing
number of studies is investigating the role of point-of-
care coagulopathy testing such as TEG in efforts to
optimize transfusion of trauma patients [32]. We investi-
gated whether blinded practitioners would follow the
clinical practices as proposed by the 2015 expert consen-
sus conference; for example, whether practicing clini-
cians without access to TEG results would transfuse FFP
to patients in whom TEG would mandate such transfu-
sion. The aim was to explore whether practice patterns
align with consensus conference guidelines on blood
transfusion in early trauma [12].
Conventional thromboelastography or TEG was uti-
lized during the study but the results were not made
available to any of the practitioners involved in the
care of the patient, thus no clinical decision was
made based on the TEG results. TEG measures the
viscoelastic changes as blood clots by spinning a
sample of blood through the TEG 5000 Hemostasis
Analyzer (Haemoscope Corporation, Niles, IL). Kaolin
was added to the citrated blood samples, which were
held for 40 min prior to analysis. Process and quality
control measures in regards to TEG during the study
are as previously described [33]. Normal TEG values
were as described by the manufacturer (R [reaction
time] 3-8 min; K [kinetic time] 1-3 min; alpha angle
[rate of clot formation] 55-78°; MA [maximum ampli-
tude] 51-69mm; LY30 [clot lysis at 30 min] 0-8%). All
clinical decisions, including post-admission blood
work were done at the discretion of the treating phy-
sicians, who were blinded to the TEG results.
Student t-test was used to compare continuous data,
while Chi-square test was used to compare categorical
data between groups. Standardized differences were used
initially to compare the balance of baseline characteristics
between the two propensity-score matched groups, where
a standardized difference less than 0.1 indicates good
balance [34]. SAS version 9.3 (SAS Institute, Cary, NC)
was used for all analyses and a two-tailed type 1 error rate
of 0.05 was used to indicate statistical significance.
Results
A total of 628 patients met trauma activation criteria
and study inclusion criteria. Of these, 142 (22.6%) were
classified as elderly while 486 (77.3%) aged <55 years old
were controls. General comparison between the two
groups is shown in Table 1. Elderly patients were more
likely to be female (41% vs. 24%; p = 0.0001), suffer blunt
mechanism of trauma (96% vs. 81%; p = 0.0005) and have
higher ISS scores (mean 25.4 vs. 21.6; p = 0.003). Elderly
patients had a higher incidence of ARDS and pulmonary
embolism, but not of other major trauma-related com-
plications. Elderly patients showed a trend towards in-
creased LOS (17.3 vs. 14.1 days; p = 0.077) and
nosocomial infection rates (30% vs. 24%; p = 0.15),
though these did not reach statistical significance. Over-
all, mortality was significantly higher among elderly
patients compared to controls (19% vs. 8%; p = 0.0001).
Comparison of transfusion rates is shown in Table 2.
Significantly more elderly patients received blood trans-
fusions (43% vs. 30%; p = 0.012) overall. Elderly patients
received significantly more pRBC and FFP. The higher
number of elderly patients receiving platelet or cryopre-
cipitate transfusions did not reach statistical significance
compared to controls.
Significantly less elderly patients were tachycardic
(heart rate >100 beats per minute) on arrival but more
Table 1 Full cohort demographics and hospital data
Variable Control (n = 486) Elderly (n = 142) P value
Age (mean) 31.54 68.68 <.0001
Male Sex 368 (76%) 84 (59%) 0.0001
Penetrating Mechanism 94 (19%) 6 (4%) 0.001
ISS (mean) 21.64 25.42 0.003
LOS (mean) (days) 13.09 17.30 0.08
ICU Admissions 178 (37%) 51 (36%) 0.94
Mechanic Ventilated (days) 175 (36%) 59 (42%) 0.23
ICU LOS (mean) (days) 6.70 6.17 0.73
Procedure or Operation 258 (53%) 66 (46%) 0.17
Discharged to Rehab 205 (42%) 81 (57%) 0.002
Mortality 37 (8%) 27 (19%) 0.0001
Nosocomial Infection 115 (24%) 42 (30%) 0.15
Stroke 10 (2%) 4 (3%) 0.59
ARDS 8 (2%) 10 (7%) 0.002
Acute Renal Failure 2 (0.4%) 2 (1%) 0.22
Pulmonary Embolism 5 (1%) 5 (4%) 0.05
Myocardial Infarction 0 (0%) 1 (0.7%) 0.98
ISS injury severity score, LOS length of stay, ICU intensive care unit, ARDS acute
respiratory distress syndrome
Table 2 Full cohort transfusion data
Variable Control (n = 486) Elderly (n = 142) P value
Transfused 147 (30%) 59 (42%) 0.01
Transfused 1st 24 h 97 (20%) 40 (28%) 0.04
Transfused pRBC 146 (30%) 56 (39%) 0.04
Transfused FFP 41 (8%) 21 (15%) 0.03
Transfused Platelets 36 (7%) 15 (11%) 0.23
Transfused Cryoprecipitate 17 (4%) 6 (4%) 0.69
pRBC packed red blood cells, FFP fresh frozen plasma
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of them had significant anemia with hemoglobin levels
below 100g/L. More elderly patients were coagulopathic
on hospital admission according to elevated inter-
national normalized ratio (INR), 11% compared to 3% of
controls had INR >1.5 (p = 0.0008). However, 23% of the
elderly patients with INR >1.5 were taking Coumadin,
which could account for the INR findings. Other markers
of coagulopathy such as platelet count, fibrinogen serum
levels (18.3% vs. 16.7%; p = 0.69) and most TEG measure-
ments (27% vs. 33%; p = 0.18) were not statistically different
when elderly patients were compared to controls, as shown
in Table 3. However, elderly were more likely to have ab-
normalities in MA than controls (19% vs. 11%, p = 0.02).
When we analyzed the blood transfusion rates in patients
with abnormal coagulation tests (TEG or fibrinogen levels),
no statistical differences could be detected between young
and elderly; results are shown in Table 4.
The next investigation was whether practicing clini-
cians without access to point-of-care TEG results would
transfuse blood products to patients in whom the TEG
test would recommend transfusion according to the rec-
ommendations of the 2015 expert consensus conference
[12]. Any abnormal TEG was associated with the trans-
fusion of pRBC in 42.2% of patients, though was associ-
ated with the need for FFP, platelets, or cryoprecipitate
in only 20.5%, 20.5%, and 9.6% respectively. In this study
we observed a discrepancy between the practitioner de-
cision to transfuse blood products and the recommenda-
tions of the 2015 consensus guidelines, in which
cryoprecipitate should be transfused for abnormalities in
clot strength, such as TEG MA [12]. Similarly, abnormal
serum fibrinogen levels or TEG LY30 on admission were
predictive of any blood transfusion (68.2%, 76.9%), but
not cryoprecipitate specifically (15.9%, 46.2%), which
was the standard treatment for hypofibrinogenemia at
our institution during the study period. Patients with ab-
normal LY30 on admission had mortality rates of 60% in
the younger cohort and 100% in the elderly, which is
consistent with current data regarding this high mortal-
ity group [9].
Propensity-matched analysis results are shown in
Tables 5 and 6, where 61 elderly were matched to 61
control subjects. After adjustment, a number of the pre-
viously observed differences between controls and eld-
erly were resolved, including need for pRBC transfusion,
INR >1.5, tachycardia, and mortality. Mortality results
were directly compared in the matched cohort, and
causes of death were similar between groups with equal
proportions of deaths being attributable to bleeding
complications.
There was an increased rate of FFP transfusion (33 vs.
13%; p = 0.012), though 6 of the 20 elderly patients that
received FFP were on Coumadin. The younger cohort
were more likely to have a base deficit <6 and a fibrino-
gen level <2.0. The elderly were more likely to be dis-
charged to a rehabilitation facility, though mortality
differences were not statistically significant. Abnormalities
in TEG data for reaction time and alpha angle were more
common in the younger cohort.
Subgroup analysis using an age cut-off of 65 years to
define elderly was also performed, specifically to deter-
mine whether our chosen age cut-off of 55 was
Table 3 Full cohort vital signs, conventional laboratory and TEG
values on admission
Variable Control (n = 486) Elderly (n = 142) P value
Heart Rate >100 bpm 192 (40%) 38 (27%) 0.01
Systolic BP <100 mmHg 18 (4%) 9 (6%) 0.18
Temperature <35C 28 (6%) 7 (5%) 0.81
Hemoglobin <100g/L 24 (5%) 19 (13%) 0.0009
Platelet count <100x109/L 12 (3%) 3 (2%) 0.80
Fibrinogen <2.0 g/L 81 (17%) 26 (18%) 0.69
INR > 1.5 15 (3%) 15 (11%) 0.0008
pH <7.2 27 (6%) 9 (6%) 0.97
Base Deficit >6 98 (20%) 28 (20%) 0.24
2+ Abnormal TEG values 60 (12%) 23 (16%) 0.23
Any Abnormal TEG value 133 (27%) 47 (33%) 0.18
Abnormal R 57 (12%) 11 (8%) 0.16
Abnormal K 51 (10%) 21 (15%) 0.18
Abnormal alpha 74 (15%) 18 (13%) 0.39
Abnormal MA 55 (11%) 27 (19%) 0.02
Abnormal LY30 10 (2%) 3 (2%) 0.98
INR international normalized ratio, TEG thromboelastography, R reaction time,
K kinetic time, MA maximum amplitude, LY30 clot lysis after 30 minutes
Table 4 Patients with abnormal TEG or fibrinogen values on
admission
Variable Control (n= 486) Elderly (n = 142) P-value
Any Abnormal TEG value 60 (12%) 23 (16%) 0.26
Any transfusion 24 (40%) 11 (48%) 0.52
Transfused pRBC 24 (40%) 11 (48%) 0.52
Transfused FFP 13 (22%) 4 (17%) 0.67
Transfused Platelets 13 (22%) 4 (17%) 0.67
Transfused Cryoprecipitate 7 (12%) 1 (4%) 0.33
Abnormal LY30 10 (2%) 3 (2%) 0.98
Any transfusion 8 (80%) 2 (67%) 0.63
Transfused Cryoprecipitate 6 (60%) 0 (0%)
Mortality 6 (60%) 3 (100%)
Abnormal Fibrinogen 81 (17%) 26 (18%) 0.69
Any transfusion 53 (65%) 20 (77%) 0.28
Transfused Cryoprecipitate 13 (16%) 4 (15%) 0.94
TEG thromboelastography, pRBC packed red blood cells, FFP fresh frozen plasma,
LY30 clot lysis after 30 minutes
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appropriate (data not shown). Cohort sizes were not felt
to be large enough to allow for meaningful comparisons
between more selective age subgroups. The new elderly
cohort consisted of 88 patients. Only a few changes were
found when compared to the 55 year cut-off. Increased
rates of platelet transfusion and LOS in the elderly
reached statistical significance in this analysis. For the
propensity-matched analysis of this subgroup, the only
major difference from the previous analysis was an in-
creased mortality rate in the elderly population (36 vs.
16%, p < 0.05).
Discussion
The main findings of the present study are that, in un-
adjusted analysis of all trauma activations at a single
institution, elderly patients tend to be more severely in-
jured with higher rates of blood transfusion and mortal-
ity. Propensity-matched analysis was performed to
specifically analyze the role of TEG in this population
and resolved many of the differences between cohorts,
while also suggesting a decreased rate of acute trauma
coagulopathy in the elderly.
Our results endorse earlier findings, particularly that
elderly patients have worse clinical outcomes after
trauma. This was true in regards to complications, re-
habilitation requirements and mortality. However, this
needs to be taken in light of the fact that elderly patients
in our cohort were also more severely injured, with a
mean injury severity score of 25.4 vs. 21.6 (p = 0.003).
While higher ISS could account for the higher mortality,
it may not be the sole explanation. Another explanation
for the higher observed mortality is the increased
utilization of blood products in the elderly cohort.
Higher transfusion volumes have been associated with
mortality in trauma patients even when controlling for
injury burden [35], and this effect may be even more
pronounced in older patients.
Furthermore, the higher ISS measurements in the
elderly supports the findings from American trauma da-
tabases [19–23] that older patients are frequently under-
triaged to tertiary trauma centres; a major problem
considering that geriatric patients tend to do worse
when admitted to non-trauma centres. In Florida they
were able to show statistically significant improvements
in mortality when admitted to a designated trauma
centre [36]. Our data supports advocacy for improved
triage of elderly patients, even with relatively normal
physiology and seemingly benign mechanisms of injury.
In terms of transfusion practices, elderly patients seem
to be transfused more readily than their younger coun-
terparts. Statistically significant differences in ISS, INR,
and anemia rates may account for this. Elderly patients
are also more likely to have more co-morbidities and use
of anticoagulants and/or antiplatelet agents (20% vs. 1%
in this study). It has also been well established that eld-
erly patients have decreased physiologic reserve and
present with less reliable vital signs [26, 37]. Despite nor-
mal admission vitals, elderly patients are more prone to
decompensation over time; clinicians may therefore
more aggressively resuscitate these patients, particularly
in the period before internal bleeding has been reliably
Table 6 Propensity-score matched vital signs, conventional
laboratory and TEG values on admission
Variable Control (n = 61) Elderly (n = 61) P-value
Heart Rate >100 bpm 22 (36%) 16 (26%) 0.16
Systolic BP <100 mmHg 7 (11%) 8 (13%) 0.89
Temperature <35C 11 (18%) 5 (8%) 0.11
Hemoglobin <100g/L 9 (15%) 17 (28%) 0.08
Platelet count <100x109/L 5 (8%) 2 (3%) 0.26
Fibrinogen <2.0g/L 27 (44%) 20 (33%) 0.05
INR > 1.5 11 (18%) 11 (18%) 0.86
pH <7.2 11 (18%) 5 (8%) 0.09
Base Deficit >6 28 (46%) 17 (28%) 0.01
2+ Abnormal TEG values 12 (20%) 12 (20%) 1.00
Any Abnormal TEG value 29 (48%) 22 (36%) 0.20
Abnormal R 14 (23%) 5 (8%) 0.03
Abnormal K 12 (20%) 11 (18%) 0.66
Abnormal alpha 20 (33%) 7 (11%) 0.002
Abnormal MA 10 (16%) 14 (23%) 0.51
Abnormal LY30 1 (2%) 2 (3%) 0.61
INR international normalized ratio, TEG thromboelastography, R reaction time,
K kinetic time, MA maximum amplitude, LY30 clot lysis after 30 minutes
Table 5 Propensity-score matched patient outcomes and
transfusion data
Variable Control (n = 61) Elderly (n = 61) P-value
ICU Admissions 41 (67%) 37 (61%) 0.52
Mechanically Ventilated 44 (72%) 40 (66%) 0.43
Discharged to Rehab 27 (44%) 40 (66%) 0.02
Mortality 22 (37%) 17 (28%) 0.33
Nosocomial Infection 19 (31%) 30 (49%) 0.04
Stroke 11 (18%) 3 (5%) 0.03
ARDS 1 (2%) 8 (13%) 0.04
Acute Renal Failure 0 (0%) 2 (3%) 0.99
Pulmonary Embolism 0 (0%) 4 (7%) 0.98
Transfused 55 (90%) 57 (93%) 0.51
Transfused 1st 24 h 31 (51%) 38 (62%) 0.20
Transfused pRBC 55 (90%) 54 (89%) 0.77
Transfused FFP 8 (13%) 20 (33%) 0.01
Transfused Platelets 6 (10%) 14 (23%) 0.06
Transfused Cryoprecipitate 2 (3%) 5 (8%) 0.26
ICU intensive care unit, ARDS acute respiratory distress syndrome, pRBC packed
red blood cells, FFP fresh frozen plasma
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excluded. In addition, elderly patients may externally ap-
pear unwell due to non-trauma related baseline changes
such as frailty, age-related skin changes, and co-
morbidities. At times these factors lead to inappropriate
transfusion decisions in the elderly.
Outside the acutely injured population, altered co-
agulopathy in the elderly has been previously studied,
although conclusions have been conflicting. Roeloffzen
et al. showed that baseline TEG values may actually
vary with age, showing that elderly patients were
more hypercoagulable [38]. However, this baseline hy-
percoagulability was not confirmed by a larger study
using normal subjects performed at our own institu-
tion [13]. Age-based differences in TEG has also been
looked at in peri-operative patients, though again the
data was conflicting, with one study favoring a hypo-
coagulable state in the elderly versus hypercoagulabil-
ity in another [14, 15].
To our knowledge this is the first study to look specif-
ically at alterations in TEG following acute trauma in
the elderly. After controlling for gender, mechanism,
time from injury, head injury, injury severity, and need
for operative intervention, we found a significant differ-
ence favoring the early development of trauma coagu-
lopathy in younger patients. Despite similar statistics in
this propensity-matched cohort, including admission vi-
tals, transfusion, and mortality, the young still showed
more frequent abnormalities in reaction time and alpha
angle on TEG analysis, and lower fibrinogen levels. This
trend persisted using an age cutoff of 65, though with a
shift in mortality favoring the young. So, while elderly
patients do seem to develop a similar coagulopathy after
trauma, this appears less pronounced possibly due to a
baseline increase in clotting factor concentration [16].
Unfortunately, our data includes only a minority of pa-
tients that required a massive transfusion and is there-
fore underpowered to comment on relationships
between blood transfusion and outcome in this high risk
group. However, based on our results further study
seems warranted.
If our results are confirmed it will have significant im-
pact on resuscitation practices in a growing trauma sub-
population. We observed an increase in trauma-induced
coagulopathy in the young, compared to drug-induced
coagulopathy in the elderly. Unfortunately, drug-
induced coagulopathy is not always diagnosed using
viscoelastic testing such at TEG [12]. This would suggest
that our approach in the elderly should be more focused
on obtaining accurate medication histories and the use of
prothrombin complex concentrate, vitamin K, and other
reversal agents. Viscoelastic hemostatic assays have
proven efficacy in reducing FFP and platelet transfusions
in hepatic transplantation, cardiac surgery [39, 40], and
most recently trauma populations [35]. Given our results,
however, the utility and potential pitfalls of these point-of-
care coagulation tests in the geriatric trauma population
are uncertain. Specifically, the interaction between anti-
coagulant medications and the acute coagulopathy of
trauma has not been previously addressed and has
the potential to alter management in the elderly
trauma population. Similarly, what affect do major co-
morbidities such as heart and renal failure have on
the acute coagulation of trauma and viscoelastic test-
ing? A prospective, multicenter study utilizing visco-
elastic and conventional coagulation testing would be
ideal to further clarify coagulopathy and consequent
management of the elderly trauma patient.
This study has a number of limitations. First, there is
no clear definition for “elderly”. We chose 55 as a cut-off
based on the understanding that physiologic changes
occur around this age that impair many patient’s toler-
ance to major trauma. Furthermore, subgroup analysis
of those aged 65 and over did reveal similar trends, al-
beit with a smaller sample size. Second, our data is made
up of a heterogeneous group of patients, as with any
trauma database. Propensity-matching helped to limit
the differences between the groups, but this remains a
difficult factor to minimize. For example, differences in
bone density and other underlying co-morbidities are
not always clearly defined in the data. Third, the
decision-making process in regards to transfusion is not
documented. We know that the clinicians did not have
access to the TEG data at the time of treatment, but it
remains unclear whether each individual unit was or-
dered based on vital signs, medical history, laboratory
data, or other clinical information. Furthermore, the
transfusion practices in place at the time of the study
may not be characteristic of those used today. Changes
in institutional transfusion protocols implemented over
this time frame include the now routine use of tranex-
amic acid in bleeding trauma patients, massive transfu-
sion protocols, and quality improvement initiatives.
Finally, this study was performed at a single centre and
used only conventional TEG as opposed to rapid TEG
or ROTEM, which limits its external validity.
Despite its limitations, this remains the first study
to our knowledge in the literature to look specifically
at modern day transfusion practices and TEG-based
coagulopathy in the geriatric trauma population. Our
results show that elderly patients at our trauma
centre are more likely to be transfused pRBC and
FFP, though this may be due to undertriage and in-
creased anemia rates. Also, elderly patients seem to
be less susceptible to alterations in TEG and therefore
trauma-induced coagulopathy. While we have shown,
in another way, that geriatric patients are different,
there are still many gaps to fill in to optimize resusci-
tation in this high-risk patient group.
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Conclusions
Our results suggest that elderly trauma patients are more
likely to receive blood products when admitted to a trauma
centre, though this may be attributed to under-triage. It is
not clear whether the pathophysiology of coagulopathy in
trauma is equivalent in geriatric patients, or consequently
its management, and further study is therefore warranted.
Abbreviations
AIS: Abbreviated injury score; ARDS: Acute respiratory distress syndrome;
ATLS: Advanced trauma life support; FFP: Fresh frozen plasma; ICU: Intensive
care unit; INR: International normalized ratio; ISS: Injury severity score;
k: Kinetic time; LOS: Length of stay; LY30: Clot lysis after 30 minutes;
MA: Maximum amplitude; pRBC: packed red blood cells; R: Reaction time;
ROTEM: Rotational thromboelastometry; TEG: Thromboelastography
Acknowledgements
We would like to acknowledge Sandro Scarpelini for his work on preparing
the initial trauma database.
Funding
No dedicated external funding was acquired.
Availability of data and materials
The datasets generated and/or analyzed during the current study are not
publicly available due to confidentiality reasons but are available from the
corresponding author on reasonable request.
Authors’ contributions
BM, BN, and SR contributed to study design and hypothesis development.
SH performed the statistical analysis. BM prepared the manuscript. All authors
contributed to manuscript revisions and approved the final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Ethics approval for conduct of the study was obtained from both the Sunnybrook
Research Ethics Board and the Toronto Academic Health Sciences Network
Research Ethics Board. All information accessed was already available through the
existing database so additional consent was not required, though all study
investigators did sign a confidentiality agreement.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Surgery, University of Alberta, 205 – 3017 66 St NW,
Edmonton, AB T6K 4B2, Canada. 2Department of Surgery, Sunnybrook Health
Sciences Centre, 2075 Bayview Ave, Room H171, Toronto, ON M4N 3M5,
Canada. 3Institute for Clinical Evaluative Sciences, Sunnybrook Health
Sciences Centre, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.
4Department of Surgery, St. Michael’s Hospital, 30 Bond Street, 3-074
Donnelly Wing, Toronto, ON M5B 1W8, Canada.
Received: 18 October 2016 Accepted: 15 March 2017
References
1. Duchesne JC, Hunt JP, Wahl G, Marr AB, Wang YZ, Weintraub S, et al.
Review of current blood transfusions strategies in a mature level I trauma
center: were we wrong for the last 60 years? J Trauma. 2008;65:272–6.
2. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al.
The ratio of blood products transfused affects mortality in patients receiving
massive transfusions at a combat support hospital. J Trauma. 2007;63:805–13.
3. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA,
et al. Increased plasma and platelet to red blood cell ratios improves outcome in
466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447–58.
4. Teixeira PG, Inaba K, Shulman I, Salim A, Demetriades D, Brown C, et al.
Impact of plasma transfusion in massively transfused trauma patients.
J Trauma. 2009;66:693–7.
5. Camazine MN, Hemmila MR, Leonard JC, Jacobs RA, Horst JA, Kozar RA,
Bochicchio GV, Nathens AB, Cryer HM, Spinella PC. Massive transfusion
policies at trauma centers participating in the American college of surgeons
trauma quality improvement program. J Trauma. 2015;78(6):S48–53.
6. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma.
2003;54:1127–30.
7. Engels PT, Rezende-Neto JB, Al Mohammed M, Scarpelini S, Rizoli SB, Tien
HC. The natural history of trauma-related coagulopathy: implications for
treatment. J Trauma. 2011;71:S448–55.
8. Ives C, Inaba K, Branco BC, Okoye O, Schochl H, Talving P, et al. Hyperfibrinolysis
elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg.
2012;215:496–502.
9. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schochl H, et al.
Hyperfibrinolysis at admission is an uncommon but highly lethal event
associated with shock and prehospital fluid administration. J Trauma Injury
Infect Crit Care. 2012;73(2):365–70.
10. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, et al.
Admission rapid thrombelastography can replace conventional coagulation
tests in the emergency department: experience with 1974 consecutive
trauma patients. Ann Surg. 2012;256(3):476–86.
11. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of
thrombelastography in assessment of trauma patient coagulation. J Trauma.
1997;42:716–20.
12. Inaba K, Rizoli S, Veigas PV, Callum J, Davenport R, Hess J, Maegele M. 2014
Consensus conference on viscoelastic test–based transfusion guidelines for
early trauma resuscitation: Report of the panel. J Trauma. 2015;78(6):1220–9.
13. Scarpelini S, Rhind SG, Nascimento B, Tien H, Shek PN, Peng H, et al. Normal
range values for thromboelastography in healthy adult volunteers. Braz J
Med Biol Res. 2009;42(12):1210–7.
14. Boldt J, Haisch G, Kumle B, Brosch C, Lehmann A, Werling C. Does coagulation
differ between elderly and younger patients undergoing cardiac surgery?
Intensive Care Med. 2002;28(4):466–71.
15. Kim CJ, Ryu KH, Park SC, Lee J. Perioperative changes in thromboelastogram
in elderly patients receiving major orthopedic surgery. Korean J Anes. 2006;
50(4):422–7.
16. Hager K, Setzer J, Vogl T, Voit J, Platt D. Blood coagulation factors in the
elderly. Archives of gerontology and geriatrics. 1989;9(3):277–82.
17. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener
J, Fried LP. Frailty and activation of the inflammation and coagulation systems
with and without clinical comorbidities: results from the Cardiovascular Health
Study. Arch Intern Med. 2002;162(20):2333–41.
18. Kanapuru B, Ershler WB. Inflammation, coagulation, and the pathway to frailty.
Am J Med. 2009;122(7):605–13.
19. Lehmann R, Beekley A, Casey L, Salim A, Martin M. The impact of advanced
age on trauma triage decisions and outcomes: a statewide analysis. Am J
Surg. 2009;197:571–5.
20. Demetriades A, Sava J, Alo K, Newton E, Velmahos GC, Murray JA, et al. Old
age as a criterion for trauma team activation. J Trauma. 2001;51:754–7.
21. Caterino JM, Valasek T, Werman HA. Identification of an age cutoff for increased
mortality in patients with elderly trauma. Am J Emerg Med. 2010;28:151–8.
22. Jacobs DG. Special considerations in geriatric injury. Curr Opin Crit Care.
2003;9:535–9.
23. Ma MH, MacKenzie EJ, Alcorta R, Kelen GD. Compliance with prehospital
triage protocols for major trauma patients. J Trauma. 1999;46:168–75.
24. van Aalst JA, Morris JA, Yates HK, Miller RS, Bass SM. Severely injured
geriatric patients return to independent living: a study of factors influencing
function and independence. J Trauma. 1991;31:1096–102.
25. Broos PL, D'Hoore A, Vanderschot P, Rommens PM, Stappaerts KH. Multiple
trauma in elderly patients. Factors influencing outcome: importance of aggressive
care. Injury. 1993;24:365–8.
26 Heffernan DS, Thakkar RK, Monaghan SF, Ravindran R, Adams Jr CA, Kozloff
MS, et al. Normal presenting vital signs are unreliable in geriatric blunt trauma
victims. J Trauma. 2010;69:813–20.
27 Bergeron E, Rossignol M, Osler T, Clas D. Improving the TRISS methodology by
restructuring age categories and adding comorbidities. J Trauma. 2004;56:760–7.
Mador et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2017) 25:33 Page 7 of 8
28 Champion HR, Copes WS, Buyer D, Flanagan ME, Bain L, Sacco WJ. Major
trauma in geriatric patients. Am J Public Health. 1989;79:1278–82.
29 American College of Surgeons Committee on Trauma. Advanced Trauma
Life Support Student Manual. Chicago: American College of Surgeons
Committee on Trauma; 2009.
30 Eastridge BJ, Malone D, Holcomb JB. Early predictors of transfusion and
mortality after injury: a review of the data-based literature. J Trauma ACS.
2006;60(6):S20–5.
31 Epstein DS, Mitra B, Cameron PA, Fitzgerald M, Rosenfeld JV. Acute traumatic
coagulopathy in the setting of isolated traumatic brain injury: definition,
incidence and outcomes. Br J Neurosurg. 2015;29(1):118–22.
32 Johansson PI, Stensballe J, Oliveri R, Wade CE, Ostrowski SR, Holcomb JB.
How I treat patients with massive hemorrhage. Blood. 2014;124(20):3052.
33 Rizoli SB, Scarpelini S, Callum J, Nascimento B, Mann KG, Pinto R, et al.
Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma
Injury Infect Crit Care. 2011;71:S427–34.
34 Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of
different propensity score models to balance measured variables between
treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26(4):
734–53. doi:10.1002/sim.2580.
35 Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A,
Wohlauer MV, Barnett CC, Bensard DD, Biffl WL, Burlew CC. Goal-directed
hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic
randomized clinical trial comparing a viscoelastic assay to conventional
coagulation assays. Ann Surg. 2016;263(6):1051–9.
36 Pracht EE, Langland-Orban B, Flint L. Survival advantage for elderly trauma
patients treated in a designated trauma center. J Trauma. 2011;71(1):69–77.
37 Callaway DW, Wolf R. Geriatric trauma. Emerg Med Clin North Am. 2007;25:
837–60.
38 Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, Veeger NJ, Bosman L, de
Wolf JTM. In normal controls, both age and gender affect coagulability as
measured by thrombelastography. Anesth Analg. 2010;110(4):987–94.
39 Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, et al.
Thromboelastography-guided transfusion decreases intraoperative blood
transfusion during orthotopic liver transplantation: randomized clinical trial.
Transplant Proc. 2010;42(7):2590–3.
40 Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, Aljodi M, et al. Thromboelastography‐
based transfusion algorithm reduces blood product use after elective cabg: a
prospective randomized study. J Card Surg. 2009;24(4):404–10.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Mador et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2017) 25:33 Page 8 of 8
